Saw Palmetto for Hair Loss: Oral vs. Topical, and What the Trials Actually Tested
If you have already decided saw palmetto is worth trying, the format question is the one that actually matters next: an oral capsule and a topical oil are supported by different trials, and a rinsed-off shampoo has not been tested in either kind of study. The oral evidence is the deeper of the two records and includes the only significant reduction in hormone levels found anywhere in this ingredient's hair-loss research, while the sole controlled trial of a topical formulation used a 20% oil that was rinsed off after 30 minutes rather than a product washed out within minutes. That distinction matters for what the Saw Palmetto DHT Shampoo can honestly be expected to do in a routine.
- Four oral trials exist, ranging from a ten-person pilot to a sponsor-funded interim report, and only one of them measured serum DHT directly.
- One controlled trial has tested a topical saw palmetto formulation, and it applied a 20% oil that stayed on the scalp for 30 minutes before being washed off, a contact window well beyond the couple of minutes a shampoo typically gets, but still a rinsed-off product rather than a leave-on one.
- No trial has tested a saw palmetto shampoo, so any expectation for the shampoo has to come from reasoning about contact time, not from a study result.
What the “blocks DHT” claim on a saw palmetto label actually rests on
Saw palmetto's fatty acids and phytosterols have inhibited 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT), in laboratory assays. That is a genuine finding, and it is also where the certainty ends: an enzyme reacting to an extract in a test tube is not the same as a measurable change on a living scalp, and the gap between the two is exactly what the trials below try to close. For the fuller explanation of how DHT reaches a follicle and why it shrinks hair over successive growth cycles, the mechanism behind DHT-driven hair loss is covered separately; here, the short version is enough to make sense of what each study actually measured. Some trials counted hairs. One measured the hormone itself. Those are different kinds of evidence, and keeping them apart is the point of reading the studies individually rather than taking the label's claim at face value.
Oral saw palmetto: four trials, four different confidence levels
The oral research did not arrive all at once, and each study added a different piece while carrying its own limitations. Reading them in the order they were published shows how the evidence base was actually built, rather than presenting a single average result that hides how thin some of the underlying data is.
The first controlled study, run by Prager and colleagues in 2002, was a small double-blind, placebo-controlled pilot testing an oral formulation that combined saw palmetto with beta-sitosterol. Six of the ten people on the active treatment were rated improved (source: Prager et al., J Altern Complement Med, 2002). The authors described it as the first controlled evidence that a naturally occurring 5-alpha-reductase inhibitor could do anything measurable in androgenetic alopecia, which is a meaningful milestone, but the active arm held ten people, so the result establishes a possibility rather than a reliable effect size.
A decade later, Rossi and colleagues ran a much larger comparison: 100 men over 24 months, taking oral Serenoa repens at 320 mg a day against finasteride at 1 mg a day. Thirty-eight per cent improved on saw palmetto compared with 68 per cent on finasteride, and the pattern of where each treatment worked also differed: saw palmetto's improvement concentrated at the vertex, while finasteride acted at both the vertex and the hairline (source: Rossi et al., Int J Immunopathol Pharmacol, 2012). The study's length and size are real strengths, but it was open-label with no placebo arm, so neither the men nor the researchers were blinded to who was taking what. Anyone weighing this trial against Prager's should weight it for scale and duration, and discount it somewhat for the missing placebo control.
The strongest single piece of oral evidence came from Sudeep and colleagues in 2023: a double-blind, placebo-controlled trial with four arms, 80 subjects and a 16-week duration, testing a standardised saw palmetto oil (branded VISPO) in both an oral 400 mg capsule and a topical form, each against its own placebo. The oral capsule reduced hair fall by up to 29 per cent and produced a measurable drop in serum DHT compared with placebo (source: Sudeep et al., Clin Cosmet Investig Dermatol, 2023). That DHT reading is the detail worth sitting with, because it is the only trial in this list that measured the hormone itself rather than inferring an effect from a hair count. Neither the oral nor the topical arm showed a significant change in the anagen-to-telogen ratio, a detail that keeps this from being a complete picture of how the hair cycle responded.
The most recent trial, published by Ablon in 2025, tested a proprietary saw palmetto fatty-acid extract in 60 subjects, split 40 active to 20 placebo and including women for the first time in this line of research. It was sponsored by Valensa International, the manufacturer of the extract being tested, and it reports only 90-day interim results from a study designed to run 180 days (source: Ablon, J Cosmet Dermatol, 2025). The interim data showed a statistically significant increase in terminal hair counts versus placebo, which is a genuine result, though a reader should hold two qualifiers in mind at once: the funding source and the fact that half the planned observation period has not yet been reported.
Reading the trials side by side
| Study | Design | Size & duration | Result |
|---|---|---|---|
| Prager 2002 | Double-blind, placebo-controlled pilot | 10 in the active arm; duration not specified as long-term | 6 of 10 rated improved |
| Rossi 2012 | Open-label, no placebo, vs finasteride | 100 men, 24 months | 38% improved, concentrated at the vertex (vs 68% on finasteride, both sites) |
| Sudeep 2023 (oral arm) | Double-blind, placebo-controlled | 80 subjects, 16 weeks | Hair fall reduced up to 29%; serum DHT dropped significantly |
| Ablon 2025 | Double-blind, placebo-controlled, sponsor-funded, interim | 60 subjects (40 active/20 placebo), 90-day interim of a 180-day study | Significant increase in terminal hair counts |
Topical saw palmetto: what the one real head-to-head trial found
The topical arm of the Sudeep 2023 trial is, at the time of writing, the only controlled study of a topical saw palmetto formulation for hair loss, which makes it worth isolating from the oral results rather than folding it into the same summary. Subjects applied a 20 per cent saw palmetto oil solution, 5 mL once daily, and washed it off 30 minutes after application. Hair fall dropped 22.19 per cent and hair density increased 7.61 per cent compared with placebo, and both changes reached statistical significance.
What the topical arm did not show matters just as much as what it did. Serum DHT was measured in this arm too, but where the oral capsule produced a significant drop, the topical oil showed no significant change in DHT versus placebo, so the hormone-level result belongs to the capsule rather than the oil. And as with the oral arm, the anagen-to-telogen ratio did not change significantly, so the trial demonstrates less hair loss and more density rather than a confirmed shift in the growth cycle itself. Even with 30 minutes of scalp contact, far longer than a shampoo wash gets, the topical oil still did not move the hormone reading, which says more about what a rinsed-off product can realistically expect from DHT than a simple absence of data would.
Why a rinsed-off shampoo is a different question than a capsule or a leave-on oil
No trial, including the Sudeep topical arm, has tested a wash-off shampoo formulation of saw palmetto. That gap is a matter of contact time rather than concentration: the topical trial's oil stayed on the scalp for 30 minutes, an oral capsule circulates through the body for as long as it is taken, and a shampoo typically gets a couple of minutes of contact before it goes down the drain. Whatever a shampoo's actives can accomplish in that shorter window has to be argued from first principles, because the studies above simply were not built to answer it.
That is also the framing the product's own description takes. The Saw Palmetto DHT Shampoo is built around saw palmetto fruit extract alongside 1 per cent niacinamide, 0.2 per cent caffeine and two supporting peptides, and its own copy is direct about the limits of a wash format: the saw palmetto's DHT finding is a laboratory result, not a demonstrated scalp effect, and nobody should read it as finasteride in a bottle. The niacinamide is the ingredient with the least argument attached to it in a rinse-off product, since it supports the skin barrier and settles redness and irritation on contact, a scalp-comfort role rather than a growth one. The caffeine is included at the concentration used in a published leave-on study, but delivered here by a wash rather than a leave-on serum, and the more relevant finding for a shampoo specifically is that caffeine massaged in and rinsed out has been measured reaching the follicle and remaining detectable there for roughly a day, which is evidence of delivery rather than evidence of growth.
Read together, that makes the shampoo a reasonable choice for the wash step you were going to take anyway, particularly if your scalp runs oily or feels congested, rather than a substitute for the oral trials' results. Someone who wants to compare saw palmetto against the range's other minoxidil-free actives on the same evidence-graded basis can find that comparison in the guide to natural DHT blockers.
Deciding what to expect, and when to loop in a professional instead
Every result above comes from a study of 16 weeks or longer, several running to 24 months, so a realistic timeline for any change starts in months rather than weeks. None of the trials tested a shampoo, so applying their percentages to a wash-off product would overstate what is known. Saw palmetto in either studied format is also not a substitute for the regrowth evidence behind minoxidil, which remains the only active in the Quintéa range with an FDA-recognised regrowth indication; the Minoxidil Topical Solution is the more direct starting point for someone prioritising the strongest evidence available, and mentioning it here is a matter of catalogue fairness rather than a dismissal of saw palmetto as a supporting choice.
Two situations call for a doctor rather than a supplement aisle decision. Hair loss that is sudden, patchy, scarring, or accompanied by scalp pain needs a clinical assessment before anything else. And because Rossi 2012 used finasteride as its comparator, it is worth being explicit that starting or stopping a prescription medicine is a conversation to have with a doctor, not a decision to make from a trial summary; nothing here should be read as dosing guidance for finasteride or any other prescription treatment. Readers who take other medications or supplements and want to check saw palmetto against them specifically should read the saw palmetto drug interactions guide before combining anything.
FAQ
Does the saw palmetto shampoo lower DHT the way the capsule does?
No trial has measured that for a shampoo. DHT was measured in both arms of the Sudeep 2023 trial, but only the oral 400 mg capsule produced a significant drop versus placebo; the topical oil, even with 30 minutes of scalp contact, showed no significant change, and neither result transfers to a rinsed-off wash product.
Is saw palmetto as effective as finasteride?
In the one trial that compared them directly, Rossi 2012 found finasteride outperformed oral saw palmetto on both the proportion of men who improved and the areas of the scalp affected. That trial was open-label rather than placebo-controlled, which is worth factoring in, but the direction of the result is consistent with how the two are generally regarded: finasteride as the better-evidenced option, saw palmetto as a weaker but still-studied alternative.
How long before someone would notice anything?
The trials above ran from 16 weeks to 24 months, and nothing shorter than that has been tested. For general dosage context beyond what these trials used, the saw palmetto dosage guide covers the capsule amounts studied and why a shampoo's exposure is different, and the saw palmetto side effects guide covers what the trials reported beyond hair outcomes. Anyone weighing saw palmetto specifically for prostate-related reasons rather than hair will find that evidence handled separately in the article on saw palmetto for men.